Home
Site Map
Contact DCP
Search
Skip to subnavigation.
Research Groups
Major Programs
Resources for Investigators
Publications
Active and Enrolling Trials
Closed or Completed Trials
Clinical Trials Management
Preventing & Detecting Specific Cancers
Lifestyle and Prevention
Available Funding and Grants
Recently Funded Projects
Latest News and Accomplishments
Upcoming Meetings and Events
Meetings and Events Archive
History and Mission
Offices and Research Groups
DCP Staff Directory
DCP Employee Information
Contact DCP
Skip to main content.
Active and Enrolling Trials
Closed or Completed Trials
Clinical Trials Management
Community Clinical Oncology Program
Early Phase Prevention Trials Consortia
Master Agreement Mechanism
Protocol Information Office
Quick Links
PLCO Cancer Screening Trial
Community Clinical Oncology Program (CCOPs)
Early Detection Research Network (EDRN)
Current Funding Opportunities
DCP Publications
Early Phase Prevention Trials Consortia
Step 5: Closing Out a Cancer Prevention Clinical Trial
Forms & Guidelines
Pharmacokinetic and Biomarker Methods Development
(pdf, 18kb)
DCP Site Monitoring Manual, Section 5.5
(pdf, 35kb)
Record Retention Requirements (CFR 21 312.56) for Institutional Review Board Records
Record Retention Requirements (CFR 21 312.57) for Financial Disclosures
Record Retention Requirements (CFR 21 312.62) for Drug Disposition and Case Histories
DCP Guidelines for Agent Returns
(doc, 32kb)
DCP Agent Return form - DCP Version of NIH 986
(doc, 71kb)
Pharmacy Audit Report
(pdf, 21kb)
Step 5
Final Site Visit and Audit
Investigational Agent Accountability and Return
Biologic Specimens
Archiving
Forms & Guidelines
Step 1
Step 2
Step 3
Step 4
